Get started
Author

S. Matsushita

Observed names: Matsushita Shigeto, Shigeto Matsushita
ORCID: 0000-0003-2001-5341
Observed ORCID: 0000-0003-2001-5341
OpenAlex ID: A5069733827
Real‐World Efficacy of Chemotherapy in Patients With Advanced Unresectable Extramammary Paget Disease: A Retrospective Multicenter Study of 138 Japanese Patients
2025 · Azusa Miyashita, Satoshi Fukushima, et al. · The Journal of Dermatology · 2
PDF
Genomic and transcriptomic analyses of melanoma in Japanese patients reveal candidate biomarkers for immune checkpoint inhibitor responders
2026 · T. Kimura, N. Tanaka, et al. · Communications Medicine · 1
PDF
Imaging–Pathology Correlation and Risk Stratification in Eccrine Porocarcinoma
2026 · T. Ikoma, K. Fujii, et al. · EJC Skin Cancer
Adjuvant therapy with locoregional interferon-beta versus surgery alone for resected stage II/III cutaneous melanoma: A multicenter randomized phase III trial (JCOG1309, J-FERON)
2026 · K. Namikawa, D. Ogata, et al. · EJC Skin Cancer
PDF
The role of surgery and radiotherapy in the management of stage I–III Merkel cell carcinoma: A multicenter retrospective study in Japan
2025 · E. Nakano, M. Nakamura, et al. · EJC Skin Cancer
762P Systemic treatment for patients with advanced Merkel cell carcinoma in Japan: A multicenter retrospective study
2024 · E. Nakano, M. Nakamura, et al. · Annals of Oncology
A retrospective multicenter study on the real-world efficacy of chemotherapy in 204 Japanese patients with advanced extra-mammary Paget's disease
2024 · A. Miyashita, S. Fukushima, et al. · EJC Skin Cancer
PDF
Age over 90 years is an unfavorable prognostic factor for resectable cutaneous squamous cell carcinoma
2024 · N. Saito-Sasaki, M. Aoki, et al. · EJC Skin Cancer
PDF
Adjuvant therapy for Asian patients with resected stage III/IV BRAF V600-mutant melanoma with more than 3 years of follow-up: A multicenter retrospective study in Japan
2024 · K. Namikawa, S. Mori, et al. · EJC Skin Cancer
491 Over 90 years of age is an unfavorable prognostic factor of cutaneous squamous cell carcinoma
2023 · N. Sasaki, M. Aoki, et al. · Journal of Investigative Dermatology
PDF
1194 Nivolumab plus PAI-1 inhibitor combined therapy for unresectable advanced melanoma: Phase II clinical trial
2023 · T. Fujimura, K. Yoshino, et al. · Journal of Investigative Dermatology
PDF
235P Evaluation of a prognostic model for head and neck cutaneous squamous cell carcinoma using a cumulative number of risk factors
2022 · R. Doi, S. Matsushita, et al. · Annals of Oncology
皮膚科医主導で取り組むがん免疫療法サポートネットワーク-Kagoshima Immunotherapy Support Network(KISNet)-
2019 · Matsushita Shigeto, Megumi Aoki, et al. · The Nishinihon Journal of Dermatology
気管切開術後創部感染に起因して IgA 血管炎を発症した症例
2016 · Kosuke Yoshifuku, Kengo Nishimoto, et al. · Nippon Jibiinkoka Gakkai Kaiho
Works count: 14
Citation count: 3
H-index: 1
I10-index:
Year
Topic
Type